Disclosures: Priyata Dutta: Nothing to Disclose, Robert Fontana: kezar pharmaceuticals: Grant/Research Support, Takeda Pharmaceuticals: Grant/Research Support, Nikhilesh Mazumder: Nothing to Disclose 1361 THE PATIENT AND KIDNEY GRAFT OUTCOMES OF SAFETY NET KIDNEY TRANSPLANTS ARE SIMILAR TO KIDNEY TRANSPLANT RECIPIENTS WITHOUT A PREVIOUS LIVER TRANSPLANT: A RETROSPECTIVE UNOS DATABASE ANALYSIS Mohanad Awadalla 1 Yong-Fang Kuo 2 Ashwani Singal 3 , 1 Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, 2 UTMB Galveston, 3 University of Louisville Background: The Organ Procurement and Transplantation Network (OPTN) implemented the allocation policy in 2017 to standardize the approach to simultaneous liver-kidney (SLK) listing and optimize the use of deceased donor kidneys
If three peptides each require 0.1 mL per dose, that is 0.3 mL total, which can sometimes be combined into a single syringe draw (from separate vials into one syringe) for a single injection
Statistical analysis Statistical analyses were conducted using IBM SPSS Statistics software (version 26.0, IBM, Chicago, IL, USA) and GraphPad Prism (version 8.2.1, GraphPad Software, San Diego, CA, USA) for data visualization
PMID 19451807
monocytogenes (Hedberg, 2011)